MondayApr 11, 2022 1:34 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Completes Name and Ticker Symbol Change

Correlate Infrastructure Partners (OTCQB: CIPI) today announced completion of the company’s corporate name change from Triccar Inc. to Correlate Infrastructure Partners Inc. In conjunction with the name change, the company’s ticker symbol changed to CIPI, effective at the open of market trading on April 11, 2022. “This name change accurately reflects Correlate's Net Zero solution scope for property owners while making it clear we are an open ecosystem supporting industry partners across North America,” said Correlate Infrastructure Partners CEO Todd Michaels. “Since the merger of two operating companies, Correlate Inc. and Loyal Enterprises LLC (dba Solar Site Design) in December…

Continue Reading

MondayApr 11, 2022 1:22 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Beginning of New Nicotine Formulation Creation, Evaluation Program

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has entered agreements with Altria Client Services LLC. According to the announcement, the agreements call for Lexaria to provide specific DehydraTECH(TM) powder-based nicotine formulations for a fee; Altria in turn will evaluate the formulations. The new agreements will continue through March 31, 2023. Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. In addition, the technology has shown the ability to increase bioabsorption with cannabinoids and nicotine by up to 10 times as well as decrease time…

Continue Reading

MondayApr 11, 2022 12:35 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Releases New Corporate Presentation, Announces Steady Growth in Key Categories

Friendable (OTC: FDBL) today released a new corporate presentation and 2022 strategy and announced additional increases in certain key metrics driving the company’s growth, as its 360 offering sees increased traction, revenue and user retention. As the Fan Pass Live platform has expanded, the company’s other brands associated with its 360 offering have exceeded expectations, with the Artist Republik and FeaturedX products and services continuing to produce positive results. “Hearing from our artists, their experiences, as well as simply listening to how our offering can better support their journey to success has been one of the most rewarding parts of…

Continue Reading

MondayApr 11, 2022 11:40 am

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Names Seasoned Transactional Attorney to Board of Directors

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has named a new member of its board of directors. The company has appointed transactional lawyer Adele Hogan to the board; Hogan will replace Carl Williams. With more than three decades of experience, Hogan has been involved in an estimated $200 billion of securities, mergers, contracts and closed deals. She is currently a partner at Lucosky Brookman, where she also serves as the cochair of the Corporate, Mergers & Securities Practice Group overseeing mergers and capital markets transactions including IPOs, SPACs, de-SPACs, corporate side of bankruptcies, securities and derivatives. Previously…

Continue Reading

MondayApr 11, 2022 9:15 am

Knightscope, Inc. (NASDAQ: KSCP) Celebrates 9th Anniversary; Enters $100M Stock Purchase Agreement with B. Riley Principal Capital

The security robot market was valued at $8.87 billion in 2020 and is expected to grow to $19.77 billion by 2026 Knightscope’s autonomous security robots bridge the gap between unmet security needs and the security demands of a rising population The committed equity facility provides Knightscope with the right to sell and issue up to $100 million of its Class A Common Stock Since the pandemic, an increased need for autonomous technology in the private security and asset protection industries has become apparent, resulting in a growing market for these solutions. The most recent census reported 325 million people living…

Continue Reading

MondayApr 11, 2022 9:15 am

The Sweet Smell of Trash: EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Growing Profits and a Dominant Position in Canada’s Renewable Natural Gas Market

Through three acquisitions, EverGen Infrastructure Corp. has rapidly emerged as a leading player in the RNG market with its specialization in waste-to-energy EverGen owns the first producing RNG facility in Western Canada and calls municipalities and FortisBC as customers EverGen recently signed an LOI to expand into Alberta through the acquisition of 67% of a RNG project that has already been contracted to supply RNG to FortisBC To many, a waist-deep heap of rotting food and agricultural waste is just garbage, but to Chase Edgelow, Chief Executive Officer of EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), it is a valuable resource…

Continue Reading

MondayApr 11, 2022 9:15 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Banking on a Decentralized Agriculture Positioning Model for a Better, Healthier Planet

Agriculture generates approximately 19-29% of total global greenhouse gas emissions and also has the highest demand for ammonia, at 80% globally This demand for ammonia is contributing to an increase in greenhouse gas emissions, through its production and additional processes  FuelPositive seeks to remedy this situation with its on-site green ammonia production technology Through its decentralized agricultural positioning model, the company aims to reduce ammonia’s overall carbon footprint while also empowering farmers by giving them fertilizer and energy independence and control over supply and costs Experts have noted, with great concern, that the current food production and distribution systems are…

Continue Reading

MondayApr 11, 2022 9:00 am

Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’

Mainstream acceptance of psychedelics took a “significant leap forward” with study results published in “Nature Medicine” Many say it is only a matter of time before FDA grants approval for psychoactive compounds to be used therapeutically SILO is focused on merging traditional therapeutics with psychedelic research for people suffering from underserved indications “The Psychedelic Revolution Is Coming,” proclaims a “New York Times” article, which notes that as a result, psychiatry may never be the same. This isn’t news for companies such as Silo Pharma (OTCQB: SILO). A developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, Silo…

Continue Reading

MondayApr 11, 2022 9:00 am

Sharing Services Global Corp. (SHRG) Travel Company Ideally Positioned as Travel Projected to Increase in 2022

TravelAdvisor survey shows demand for travel remains high with majority of respondents likely to travel this year Survey also reports that the average spend per trip for 2022 is estimated to be beyond that of 2019 SHRG’s new company will offer tremendous savings, exclusive benefits to its members Calling 2022 “the year of the travel rebound,” TripAdvisor announced results of a recent survey indicating that traveler intent for this year demonstrates high demand for booking experiences and a willingness to spend more on travel (https://ibn.fm/YL42V). This is great news for Sharing Services Global (OTCQB: SHRG), which last year launched a…

Continue Reading

MondayApr 11, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Leading the Charge toward Advancing Research on Treatments for Primary and Metastatic Central Nervous System Cancers

CNS Pharmaceuticals is a clinical stage biotechnology company focused on the development of novel treatments for brain tumors The company’s lead product candidate, Berubicin, is a novel anthracycline that is designed to cross the blood-brain barrier The blood-brain barrier ordinarily hinders the vascular delivery of therapeutic substances to brain tumors By crossing this protective barrier, Berubicin holds promise for the thousands of adult Americans diagnosed with malignant central nervous system cancers annually This year, about 25,050 adults (14,170 men and 10,880 women) will be diagnosed with malignant central nervous system (“CNS”) tumors – cancerous tumors that start in the spinal…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered